These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Does assessment of medical practices have a future? Capron AM Va Law Rev; 1996 Nov; 82(8):1623-40. PubMed ID: 16715566 [No Abstract] [Full Text] [Related]
23. Who should be responsible? Brown E Physician Exec; 1996 Jun; 22(6):38-9. PubMed ID: 10158532 [No Abstract] [Full Text] [Related]
24. Advances in medical technology: legal problems and approaches. Millman DS Caring; 1985 Jan; 4(1):11-8. PubMed ID: 10299993 [No Abstract] [Full Text] [Related]
25. Groups to Congress: hasten review of lung surgery. Weissenstein E Mod Healthc; 1996 Aug; 26(32):72. PubMed ID: 10158985 [No Abstract] [Full Text] [Related]
26. Bone mineral densitometry: SNM/ACNP opposes HCFA's intention to deny Medicare coverage. Tilyou S J Nucl Med; 1989 Feb; 30(2):139-40. PubMed ID: 2661745 [No Abstract] [Full Text] [Related]
27. Technology assessment and health benefits determination. Schaffarzick RW QRB Qual Rev Bull; 1985 Jul; 11(7):222-5. PubMed ID: 3929207 [No Abstract] [Full Text] [Related]
28. The importance of subjective values to medical technology assessment and health policy. Diamond GA J Invasive Cardiol; 1993; 5(1):17-22. PubMed ID: 10148297 [No Abstract] [Full Text] [Related]
29. Federal technology assessment programs should be limited. Schoellhorn RA Med Instrum; 1981; 15(5):291-2. PubMed ID: 7033740 [No Abstract] [Full Text] [Related]
30. Evaluation of medical-technology strategies: effects of coverage and reimbursement (first of two parts). Bunker JP; Fowles J; Schaffarzick R N Engl J Med; 1982 Mar; 306(10):620-4. PubMed ID: 7035944 [No Abstract] [Full Text] [Related]
31. Differences in the cost of antidepressants across state Medicaid programs. Kelton CM; Rebelein RP; Heaton PC; Ferrand Y; Guo JJ J Ment Health Policy Econ; 2008 Mar; 11(1):33-47. PubMed ID: 18424875 [TBL] [Abstract][Full Text] [Related]
32. Health technology assessment. The current political framework: the U.S. perspective. Young FE Isr J Med Sci; 1986; 22(3-4):173-8. PubMed ID: 3744767 [No Abstract] [Full Text] [Related]
33. The medical technologist and evaluation of health technologies. Peddecord KM Am J Med Technol; 1980 Jan; 46(1):30-2. PubMed ID: 7352464 [TBL] [Abstract][Full Text] [Related]
34. Screening mammography for older women. A case of mixed messages. Nattinger AB; Goodwin JS Arch Intern Med; 1992 May; 152(5):922-5. PubMed ID: 1580716 [No Abstract] [Full Text] [Related]
35. Ensuring adequate payment for the use of new technology. Kaden RJ Healthc Financ Manage; 1998 Feb; 52(2):46-52. PubMed ID: 10176449 [TBL] [Abstract][Full Text] [Related]
36. The cost and regulation of medical technology: future policy directions. Iglehart JK Milbank Mem Fund Q Health Soc; 1977; 55(1):25-59. PubMed ID: 559274 [No Abstract] [Full Text] [Related]
37. Health care technology: studying it at the National Center. Acosta FJ Forum (Wash); 1980 Oct; 4(4):30-2. PubMed ID: 6776022 [No Abstract] [Full Text] [Related]
38. Office of Technology Assessment health program. Banta D; Behney CJ Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():28-32. PubMed ID: 19519980 [TBL] [Abstract][Full Text] [Related]
39. Local medical review policies. Bryant N Issue Brief Cent Medicare Educ; 2004; 5(1):1-6. PubMed ID: 15002463 [TBL] [Abstract][Full Text] [Related]
40. Reflections on science, judgment, and value in evidence-based decision making: a conversation with David Eddy by Sean R. Tunis. Eddy D Health Aff (Millwood); 2007; 26(4):w500-15. PubMed ID: 17580317 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]